Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 20835 / DOSAGE - TABLET;ORAL - 35MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| RISEDRONATE SODIUM(UNII: OFG5EXG60L) (risedronic acid - UNII:KM2Z91756Z) | RISEDRONATE SODIUM | 5mg | 30mg | 35mg | 75mg | 150mg |
Inactive Ingredients
| Ingredient Name | Warner Chilcott Pharmaceuticals Inc. | Proficient Rx LP | Actavis Pharma, Inc. | Allergan, Inc. | Mylan Pharmaceuticals Inc. |
|---|---|---|---|---|---|
| ALUMINUM OXIDE(LMI26O6933) | |||||
| ANHYDROUS LACTOSE(3SY5LH9PMK) | |||||
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |||||
| CROSPOVIDONE (120 .MU.M)(68401960MK) | |||||
| CROSPOVIDONE (15 MPA.S AT 5%)(68401960MK) | |||||
| CROSPOVIDONE(2S7830E561) | |||||
| CROSPOVIDONE(68401960MK) | |||||
| FD&C BLUE NO. 2(L06K8R7DQK) | |||||
| FERRIC OXIDE RED(1K09F3G675) | |||||
| FERRIC OXIDE YELLOW(EX438O2MRT) | |||||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P) | |||||
| HYDROXYPROPYL CELLULOSE(RFW2ET671P) | |||||
| HYPROMELLOSE(3NXW29V3WO) | |||||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |||||
| HYPROMELLOSES(3NXW29V3WO) | |||||
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |||||
| MAGNESIUM STEARATE(70097M6I30) | |||||
| MANNITOL(3OWL53L36A) | |||||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |||||
| POLYDEXTROSE(VH2XOU12IE) | |||||
| POLYETHYLENE GLYCOL 8000(Q662QK8M3B) | |||||
| POLYETHYLENE GLYCOL(3WJQ0SDW1A) | |||||
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |||||
| SILICON DIOXIDE(ETJ7Z6XBU4) | |||||
| TITANIUM DIOXIDE(15FIX9V2JP) | |||||
| TRIACETIN(XHX3C3X673) |
